Holen Sie sich die Stockscreener-App
16.31
1.65%
0.5153
Bicara Therapeutics Inc Aktie (BCAX) Neueste Nachrichten
Key metrics from Bicara Therapeutics Inc.’s quarterly dataWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Stifel maintains Buy on Bicara stock with $47 target - MSN
Bicara Therapeutics stock rating reiterated as Buy by TD Cowen - Investing.com India
Promising Market Opportunity for Bicara Therapeutics in HPV-Negative Head & Neck Cancer Warrants Buy Rating - TipRanks
What analysts say about Bicara Therapeutics Inc stockTrend Following Strategies & Big Profit Small Investment - earlytimes.in
Statistical indicators supporting Bicara Therapeutics Inc.’s strengthWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Brokerages Set Bicara Therapeutics Inc. (NASDAQ:BCAX) PT at $32.25 - Defense World
How to read the order book for Bicara Therapeutics Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Can Bicara Therapeutics Inc. stock resist sector downturnsJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Optimistic Buy Rating for Bicara Therapeutics: Superior Clinical Benefits and Valuation Upside - TipRanks
What drives Bicara Therapeutics Inc stock priceMACD Histogram Signals & Calculate Profit Targets With AI Accuracy - earlytimes.in
Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Bicara Therapeutics (NASDAQ:BCAX) Shares Up 7.8%Here's What Happened - MarketBeat
Atle Fund Management AB Acquires 27,547 Shares of Bicara Therapeutics Inc. $BCAX - MarketBeat
Analyzing recovery setups for Bicara Therapeutics Inc. investors2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Bicara Therapeutics Inc. stock reversal real or fakeMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Bicara Therapeutics (NASDAQ:BCAX) Trading Down 5.5%Time to Sell? - MarketBeat
Using flow based indicators on Bicara Therapeutics Inc.New Guidance & Intraday High Probability Alerts - newser.com
Revenue Check: Will Bicara Therapeutics Inc. benefit from current market trends2025 Major Catalysts & Reliable Price Action Trade Plans - خودرو بانک
Risks Report: What makes Q32 Bio Inc. stock attractive todayJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - khodrobank.com
What does recent volatility data suggest for Bicara Therapeutics Inc.Trade Ideas & Verified Entry Point Detection - newser.com
Is a relief rally coming for Bicara Therapeutics Inc. holdersJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Is Bicara Therapeutics Incs growth already priced inMarket Sentiment Report & High Yield Stock Recommendations - خودرو بانک
What is Bicara Therapeutics Incs revenue forecastTrade Volume Report & Free Long-Term Investment Growth Plans - خودرو بانک
Volatility Watch: How cyclical is Bicara Therapeutics Incs revenue streamQuarterly Performance Summary & Entry and Exit Point Strategies - خودرو بانک
Rate Cut: What is Bicara Therapeutics Incs revenue forecastJuly 2025 Patterns & Long-Term Capital Growth Strategies - khodrobank.com
CEO Change: Is Bicara Therapeutics Inc.’s growth already priced inMarket Sentiment Summary & Weekly Top Gainers Alerts - khodrobank.com
Technical analysis overview for Bicara Therapeutics Inc. stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Is Atmus Filtration Technologies Inc stock a buy or sellJuly 2025 Big Picture & Entry Point Strategy Guides - khodrobank.com
Risk Off: What is Bicara Therapeutics Incs market position2025 Price Action Summary & Low Risk High Win Rate Picks - خودرو بانک
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):